1 May 2024

Atopic Dermatitis pharmaceutical Psoriasis

PBAC tick for new psoriasis, HS and AD options

3 April 2024

systemic sclerosis

Should we be using palliative care for scleroderma?

6 March 2024

pharmaceutical Urticaria

Can a new JAK inhibitor help urticaria?

13 December 2023

Cancer systemic sclerosis

Focus on cancer in scleroderma at ACR23

6 September 2023

COVID-19 Research Vaccination

Same arm jabs may boost immunity

6 September 2023

Clinical Research

Winners and losers in Aussie trials

23 August 2023

Cancer

Tackling autoimmune disease with CAR T-cell therapy

23 August 2023

psoriatic arthritis

Hey PRESTO! There’s the PsA

9 August 2023

Biologic Treatments Used in Dermatology Psoriasis

Predictors of multiple biologic failure in psoriasis

3 May 2023

PBS Vaccination

Shingrix greenlit for immune compromised over-18s

3 May 2023

Arthritis TGA

Black box warning but no smoking gun for JAKi

8 March 2023

Technology

AI not yet ready, says ACD

26 October 2022

Infusing promise into dermatomyositis therapy

22 June 2022

Clinical Drugs

Lupus hope found in psoriasis and cancer drugs

20 June 2022

Arthritis COVID-19 Psoriasis psoriatic arthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

11 April 2022

Psoriasis

Promising findings for PsA treatments